Study Results
Outcome measurements, participant flow, baseline characteristics, and adverse events have been published for this study.
View full resultsBasic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
139 participants
INTERVENTIONAL
2016-07-31
2017-04-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
CPAP In-home Assessment Australia
NCT02809794
CPAP In-home Assessment NZ
NCT02804919
A Study for Obstructive Sleep Apnea Using a New At-Home Sleep Test
NCT03049982
Evaluation of Obstructive Sleep Apnea (OSA) Using Portable Sleep Testing (PST) Devices on an Inpatient Stroke Unit
NCT06516354
Sleep for Stroke Management and Recovery Trial
NCT03812653
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
NA
SINGLE_GROUP
TREATMENT
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Investigational CPAP device
Fisher \& Paykel Healthcare CPAP Device
Fisher & Paykel Healthcare CPAP Device
Fisher \& Paykel Healthcare CPAP Device
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Fisher & Paykel Healthcare CPAP Device
Fisher \& Paykel Healthcare CPAP Device
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Diagnosed with Obstructive Sleep Apnea (OSA) and prescribed Positive Airway Pressure (either Continuous positive airway pressure (CPAP) or AutoCPAP)
* For experienced users of PAP (CPAP or AutoCPAP) - you must be using PAP of more than 4 hours/night for 70% during the last 30 days.
Exclusion Criteria
* Has other significant sleep disorders (e.g periodic leg movements, insomnia, central sleep apnea)
* Has obesity hypoventilation syndrome or congestive heart failure
* Requires supplemental oxygen with their PAP (CPAP or AutoCPAP) device
* Has implanted electronic medical devices (e.g cardiac pacemakers)
* Pregnant or think they may be pregnant
* Not fluent in spoken and written English.
22 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Fisher and Paykel Healthcare
INDUSTRY
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Matt Uhles
Role: PRINCIPAL_INVESTIGATOR
Clayton Sleep Institute
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Alabama Sleep Clinic
Huntsville, Alabama, United States
Pulmonary Disease Specialists - Central Florida Sleep Centre
Kissimmee, Florida, United States
Clayton Sleep Institute
St Louis, Missouri, United States
Ohio Sleep Medicine and Neurosciences Institute
Dublin, Ohio, United States
Countries
Review the countries where the study has at least one active or historical site.
Provided Documents
Download supplemental materials such as informed consent forms, study protocols, or participant manuals.
Document Type: Study Protocol and Statistical Analysis Plan
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
CIA176
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.